Gap Scanner
·
Stocks gapping ≥20% at open — earnings flagged, AI catalyst research included
| Ticker | Company | Sector | MCap | Prev Close | Open | Gap% | Earnings | Type | Conf | Key Detail |
|---|---|---|---|---|---|---|---|---|---|---|
| ODYS | Odysight.ai Inc. | Technology | 76M | — | $10.54 | +136.3% | — | partner | 7 | Odysight.ai signed a Commercial Collaboration Agreement with GACI Technologies (announced 2026-04-17) to expand AI-powered predictive maintenance into the French aerospace and defense market. This partnership marks the company's entry into France's aerospace, defense, and government aviation sectors through a local partner, representing geographic expansion of its visual sensing and predictive maintenance solutions. |
| MEHA | Functional Brands, Inc. Common Stock | Healthcare | $656291 | — | $0.17 | +80.7% | — | partner | 9 | Functional Brands Inc. (MEHA) executed binding Letter of Intent to acquire BullionFX Assets including Alchemy product for $142.9 million all-stock transaction. Acquisition provides access to blockchain-based financial ecosystem with gold-backed stablecoins, DeFi infrastructure, and physical gold audit mechanisms. Expected to enable gold-linked digital financial applications including payments, yield products, and decentralized finance. CEO Eric Gripentrog called it transformational for sharehold |
| EZGO | EZGO Technologies Ltd. | Consumer Cyclical | $14781 | — | $0.06 | +54.0% | — | restrct | 5 | EZGO Technologies announced on April 21, 2026 that its subsidiary Jiangsu EZGO New Energy Technology Co., Ltd. took full legal ownership of its self-built Changzhou manufacturing facility in China. This restructuring move enables the company to scale production of its short-distance transportation solutions. |
| CLIK | Click Holdings Limited | Industrials | 1M | — | $3.29 | +47.8% | — | — | 9 | CLIK reported strong H1 FY2026 results (six months ended Dec 31, 2025): Revenue HK$59.0M (+57.3% YoY from HK$37.5M), swung to net income of HK$2.66M vs loss in prior period. Seniors nursing sector grew over 110%. Company announced three-year strategic plan targeting HK$500M annual revenue by 2028 (~100% CAGR). Flash Mutual acquisition (15% stake for $0.64M) expected to deliver 50%+ incremental profit surge in 2027 via 'Life Care Robot' with US$2.5M profit guarantee. |
| JZXN | Jiuzi Holdings, Inc. | Consumer Cyclical | 1M | — | $1.30 | +44.2% | — | other | 6 | Jiuzi Holdings announced on 2026-05-11 realized $210,000 investment gains from DCIP (Distributed Capital Intelligence Protocol) investment with AetheriumX, plus approved a $100,000 share repurchase program. This validates the company's Digital Asset Treasury framework. Additionally, the company has multiple strategic initiatives: $30M proposed investment in AetheriumX's DCIP (announced 2026-03-16), $80M strategic investment at $2.00/share (2026-03-06), $1B Bitcoin acquisition plan for 10,000 BTC |
| PTIX | Protagenic Therapeutics, Inc. | Healthcare | 1M | — | $0.79 | +36.2% | — | other | 1 | No specific catalyst identified in provided sources dated on or before 2026-05-11. Most recent news (2026-04-23) announced Bill Nichols Jr. appointment as President to advance PT00114, a first-in-class TCAP pathway therapy. Prior catalysts include March 2026 Phytanix separation (removed $6.3M liabilities, $1M+ annualized cost savings) and OTCQB upgrade from OTC Pink. However, no earnings report, clinical trial results, regulatory approval, contract award, partnership, guidance change, or specifi |
| HPAI | Helport AI Limited | Technology | 37M | — | $1.32 | +33.9% | — | — | 1 | No specific catalyst identified in provided sources. Available news includes: (1) QuickCEP partnership announced 2026-04-09 for AI agent solution (no financial terms disclosed), (2) AI collections initiative with unnamed Asian finance company launched 2026-04-07 (no contract value), (3) Philippines event showcase 2026-03-24. None of these announcements include quantified contract values, customer names with dollar amounts, guidance changes, or approval events that would typically drive a 33.9% g |
| MRAM | Everspin Technologies, Inc. | Technology | 504M | — | $35.89 | +33.0% | — | contract | 9 | Everspin Technologies announced a $40 million agreement with a U.S. prime contractor to provide Toggle MRAM process technology capabilities and engineering services for United States Defense Industrial Base customers. This contract win was announced on 2026-04-30, alongside Q1 2026 earnings results that beat analyst expectations (Q1 guidance was $0.070-0.120 EPS; analysts expected $0.09 EPS and $14.60M revenue). |
| BZH | Beazer Homes USA, Inc. | Consumer Cyclical | 510M | — | $24.42 | +30.1% | — | contract | 10 | Dream Finders Homes submitted a bid to acquire Beazer Homes USA for approximately $704 million ($25.75 per share). Millrose Properties announced it will provide land banking capital support for the acquisition and intends to acquire homesites currently owned by Beazer Homes upon transaction completion, enabling capital-efficient growth while preserving balance sheet flexibility. |
| ACH | Accendra Health, Inc. | Healthcare | 285M | — | $4.64 | +28.9% | BMO | restrct | 8 | Accendra Health announced a comprehensive balance sheet optimization transaction exceeding $1.5 billion with commitments from existing creditors on May 11, 2026 (BMO earnings release). The deal significantly extends maturities and reduces total leverage. This follows Q1 2026 earnings results and addresses the company's high net leverage (expected 4.9-5x by end-2026). The restructuring strengthens the balance sheet materially, removing a major overhang that previously pressured the stock. |
| WOK | WORK Medical Technology Group Ltd. | Healthcare | $7410 | — | $1.60 | +25.0% | — | partner | 6 | WORK Medical announced strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. on April 13, 2026 (announced May 11, 2026). Agreement focuses on unlocking biological data value through AI and advancing the 'BioToken' assetization model. Additionally, WORK Medical was awarded Council Member certificate as Vice President Unit of Hong Kong Web3.0 Standardization Association Limited (May 1, 2026), positioning company in Web3.0 sector standardization and asset tokenization. |
| VCX | Fundrise Growth Tech Fund, LLC | Financial Services | 6.3B | — | $235.00 | +23.0% | — | partner | 6 | xStocks and Fundrise announced partnership on 2026-03-27 to tokenize the Fundrise Innovation Fund (NYSE: VCX), bringing onchain access to a diversified portfolio of high-growth private technology companies including SpaceX, OpenAI, Anthropic, and Databricks through tokenized asset infrastructure powered by Payward. Additionally, VCX announced new investment in Erebor Bank on 2026-03-23, a newly chartered national bank founded by Palmer Luckey (Oculus/Anduril co-founder) designed to serve the tec |
| GSIT | GSI Technology, Inc. | Technology | 238M | — | $10.35 | +22.5% | — | contract | 7 | GSI Technology announced it was awarded Phase One of a Smart City Project subsequent to Q4 2026 quarter end (reported May 7, 2026). Additionally, on April 28, 2026, GSI received a Phase-II U.S. Army xTech SBIR contract worth just under $2.0 million for developing a Ruggedized Edge AI Platform for Tactical Defense Applications using its Gemini-II processor. |
| MNDY | monday.com Ltd. | Technology | 3.9B | $72.07 | $87.32 | +21.2% | BMO | beat | 9 | Q1 2026 non-GAAP EPS of $1.15 beat Zacks Consensus of $0.96 (20% upside). Revenue of $351.3M grew 24% YoY, beating expectations. Non-GAAP operating margin maintained at 14% despite 190bps FX headwind. GAAP EPS $0.57 vs $0.52 YoY. Record GAAP operating income $19.8M (6% margin) vs $9.8M prior year. Strong net dollar retention 110%, with customers >$500K ARR up 74% YoY to 99 customers (6% of ARR). |
| POM | POMDOCTOR Ltd | Healthcare | 56M | — | $0.09 | +20.0% | — | — | 0 | Source documents provided contain only securities class action lawsuit reminders for PomDoctor Ltd. (NASDAQ: POM) with a lead plaintiff deadline of April 13, 2026, covering purchases between October 9, 2025 and December 11, 2025. No information about positive catalysts, contracts, approvals, guidance raises, earnings beats, partnerships, buybacks, or other events that would cause a 20% gap up is present in the available sources dated on or before May 11, 2026. |
| CEVA | CEVA, Inc. | Technology | 939M | $36.97 | $42.35 | +14.6% | BMO | beat | 9 | CEVA reported Q1 2026 non-GAAP diluted EPS of $0.04, beating Zacks Consensus Estimate of $0.02 per share. Total revenues were $27.0 million, up 11% YoY. Licensing and related revenues reached $17.8 million, up 18% YoY and the highest in three years. AI represented over 20% of licensing revenues with major production milestone: Ceva's AI DSP deployed in Renesas R-Car V4H platform entering 2026 Toyota RAV4. Signed 14 IP licensing agreements including major Bluetooth HDT full-stack solution with RF |
8–10 = trade signal
5–7 = research more
0–4 = stay out / no clear catalyst
Orange sector = Healthcare (binary event risk)
· Hover sector for industry · Hover ticker for price chart